Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved LIPFENDRA ® (enlicitide) tablets 20 mg as an adjunct ...
Tech Times on MSN

ASML raises full-year guidance as Intel ships first high-NA EUV logic chip

ASML earnings 2026 beat expectations as the Dutch chip equipment giant raised full-year guidance to between 43 and 45 billion ...